Pro-drugs containing an electron withdrawing substituent, as defined in the specification, are useful in a method for providing a patient with post administration-activated, controlled release of a biologically active compound.
包含电子吸引基团的前药,在规范中定义,对于为患者提供经过给药后激活的、受控释放
生物活性化合物的方法是有用的。